Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05179941 · ClinicalTrials.gov registry record · NA
Subscapularis Indocyanine Green Perfusion Pilot Study
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT05179941 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 10 participants.
The verdict
NCT05179941, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The Purpose of this pilot study is to evaluate the feasibility of open wide-field imaging of indocyanine green ingress and egress during total shoulder arthroplasty. This study also hopes to characterize the relationship between tissue perfusion measured with DCE-FI and different approaches and techniques used in total shoulder arthroplasty. The long term goal of this study is to determine if there is a potential relationship between perfusion and patient reported outcomes and subscapularis failure.
Interventions
- PROCEDURE Perfusion with Indocyanine green
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-02-11 |
| Est. Completion | 2022-12-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05179941
The ClinicalTrials.gov registry entry for NCT05179941 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Perfusion with Indocyanine green is the first listed.
NCT05179941 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05179941 about?
NCT05179941 is a clinical study titled "Subscapularis Indocyanine Green Perfusion Pilot Study". The Purpose of this pilot study is to evaluate the feasibility of open wide-field imaging of indocyanine green ingress and egress during total shoulder arthroplasty. This study also hopes to characterize the relationship between tissue perfusion measured with DCE-FI and different approaches and tech...
What is the current status of trial NCT05179941?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2022-02-11. Estimated completion is 2022-12-13.
What interventions are being tested in trial NCT05179941?
The interventions under investigation include: Perfusion with Indocyanine green (PROCEDURE).
Who is sponsoring clinical trial NCT05179941?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.